PT2872145T - Benzazepinas fundidas para o tratamento da síndrome de tourette - Google Patents

Benzazepinas fundidas para o tratamento da síndrome de tourette

Info

Publication number: PT2872145T
Authority: PT; Portugal
Prior art keywords: treatment; tourette syndrome; fused benzazepines; benzazepines; fused
Prior art date: 2012-07-12

Application number

PT138159884T

Other languages

English (en)

Original Assignee

Emalex Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-07-12

Filing date

2013-07-12

Publication date

2022-05-26

2013-07-12 Application filed by Emalex Biosciences Inc filed Critical Emalex Biosciences Inc

2022-05-26 Publication of PT2872145T publication Critical patent/PT2872145T/pt

Links

201000004311 Gilles de la Tourette syndrome Diseases 0.000 title 1
208000000323 Tourette Syndrome Diseases 0.000 title 1
208000016620 Tourette disease Diseases 0.000 title 1
150000008038 benzoazepines Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT138159884T 2012-07-12 2013-07-12 Benzazepinas fundidas para o tratamento da síndrome de tourette PT2872145T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261671044P	2012-07-12	2012-07-12

Publications (1)

Publication Number	Publication Date
PT2872145T true PT2872145T (pt)	2022-05-26

Family

ID=49916578

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT211700638T PT3919060T (pt)	2012-07-12	2013-07-12	Ecopipam para o tratamento de síndrome de tourette
PT138159884T PT2872145T (pt)	2012-07-12	2013-07-12	Benzazepinas fundidas para o tratamento da síndrome de tourette

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT211700638T PT3919060T (pt)	2012-07-12	2013-07-12	Ecopipam para o tratamento de síndrome de tourette

Country Status (21)

Country	Link
US (2)	US11298361B2 (pt)
EP (3)	EP2872145B8 (pt)
JP (1)	JP6181754B2 (pt)
KR (1)	KR20150029713A (pt)
CN (1)	CN104540510A (pt)
AU (1)	AU2013289922B2 (pt)
CA (1)	CA2879020C (pt)
CY (1)	CY1125221T1 (pt)
DK (2)	DK2872145T3 (pt)
ES (2)	ES3041320T3 (pt)
FI (1)	FI3919060T3 (pt)
HR (2)	HRP20251123T1 (pt)
HU (2)	HUE072922T2 (pt)
IL (4)	IL292725A (pt)
LT (2)	LT3919060T (pt)
PL (2)	PL2872145T3 (pt)
PT (2)	PT3919060T (pt)
RS (2)	RS67203B1 (pt)
SI (2)	SI3919060T1 (pt)
SM (2)	SMT202200234T1 (pt)
WO (1)	WO2014012034A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LT3057595T (lt)	2013-10-18	2020-08-10	Emalex Biosciences, Inc.	Sintezuoti benzazepinai, skirti mikčiojimui gydyti
MX2021003302A (es)	2018-09-20	2021-05-13	Ovid Therapeutics Inc	Uso de gaboxadol para el tratamiento del sindrome de tourette, los tics y la tartamudez.
CN121891333A (zh) *	2020-06-05	2026-04-21	诺埃玛制药公司	用于治疗杜尔雷斯综合征的磷酸二酯酶10抑制剂的用途
US12594281B2 (en)	2024-03-15	2026-04-07	Emalex Biosciences, Inc.	Pharmaceutical dosage forms and methods of use
WO2025194153A1 (en) *	2024-03-15	2025-09-18	Emalex Biosciences, Inc.	Pharmaceutical dosage forms and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4477378A (en)	1980-02-05	1984-10-16	Schering Corp.	Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4973586A (en)	1986-01-16	1990-11-27	Schering Corporation	Fused benzazepines, compositions of, and medical use thereof
US5302716A (en)	1986-01-16	1994-04-12	Schering Corporation	Fused benzazepines
BE1005064A4 (nl)	1991-07-03	1993-04-06	Asm Fico Tooling	Buiginrichting.
GB9127306D0 (en)	1991-12-23	1992-02-19	Boots Co Plc	Therapeutic agents
WO1995025102A1 (en)	1994-03-16	1995-09-21	Novo Nordisk A/S	Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
US5607967A (en) *	1994-10-27	1997-03-04	Merck & Co., Inc.	Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
KR20010031470A (ko)	1997-10-28	2001-04-16	둘락 노먼 씨.	포유동물의 갈망을 감소시키는 방법
BR9908392A (pt) *	1998-03-02	2000-10-31	Schering Corp	Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo
US6132724A (en)	1998-04-29	2000-10-17	City Of Hope National Medical Center	Allelic polygene diagnosis of reward deficiency syndrome and treatment
SE9904724D0 (sv)	1999-12-22	1999-12-22	Carlsson A Research Ab	New modulators of dopamine neurotransmission I
WO2003039468A2 (en)	2001-11-06	2003-05-15	Haracz John L	Antimnemonic therapy for hypermemory syndromes
US8518933B2 (en)	2009-04-23	2013-08-27	Abbvie Inc.	Modulators of 5-HT receptors and methods of use thereof
WO2011057199A1 (en) *	2009-11-06	2011-05-12	Adenios, Inc.	Compositions for treating cns disorders
US20110206782A1 (en)	2010-02-24	2011-08-25	Auspex Pharmaceuticals, Inc.	Piperidine modulators of dopamine receptor
WO2012033874A1 (en) *	2010-09-10	2012-03-15	Chipkin Richard E	Method of treating compulsive self-injurious behaviors
LT3057595T (lt)	2013-10-18	2020-08-10	Emalex Biosciences, Inc.	Sintezuoti benzazepinai, skirti mikčiojimui gydyti

2013
- 2013-07-12 PL PL13815988T patent/PL2872145T3/pl unknown
- 2013-07-12 DK DK13815988.4T patent/DK2872145T3/da active
- 2013-07-12 JP JP2015521856A patent/JP6181754B2/ja active Active
- 2013-07-12 SM SM20220234T patent/SMT202200234T1/it unknown
- 2013-07-12 CA CA2879020A patent/CA2879020C/en active Active
- 2013-07-12 ES ES21170063T patent/ES3041320T3/es active Active
- 2013-07-12 EP EP13815988.4A patent/EP2872145B8/en active Active
- 2013-07-12 KR KR1020157001403A patent/KR20150029713A/ko not_active Ceased
- 2013-07-12 RS RS20250912A patent/RS67203B1/sr unknown
- 2013-07-12 SI SI201332110T patent/SI3919060T1/sl unknown
- 2013-07-12 HU HUE21170063A patent/HUE072922T2/hu unknown
- 2013-07-12 CN CN201380036903.9A patent/CN104540510A/zh active Pending
- 2013-07-12 PT PT211700638T patent/PT3919060T/pt unknown
- 2013-07-12 SM SM20250353T patent/SMT202500353T1/it unknown
- 2013-07-12 IL IL292725A patent/IL292725A/en unknown
- 2013-07-12 US US14/414,368 patent/US11298361B2/en active Active
- 2013-07-12 RS RS20220519A patent/RS63266B1/sr unknown
- 2013-07-12 IL IL300144A patent/IL300144A/en unknown
- 2013-07-12 HU HUE13815988A patent/HUE058696T2/hu unknown
- 2013-07-12 LT LTEP21170063.8T patent/LT3919060T/lt unknown
- 2013-07-12 AU AU2013289922A patent/AU2013289922B2/en active Active
- 2013-07-12 SI SI201331993T patent/SI2872145T1/sl unknown
- 2013-07-12 FI FIEP21170063.8T patent/FI3919060T3/fi active
- 2013-07-12 HR HRP20251123TT patent/HRP20251123T1/hr unknown
- 2013-07-12 DK DK21170063.8T patent/DK3919060T3/da active
- 2013-07-12 PL PL21170063.8T patent/PL3919060T3/pl unknown
- 2013-07-12 LT LTEPPCT/US2013/050337T patent/LT2872145T/lt unknown
- 2013-07-12 EP EP21170063.8A patent/EP3919060B1/en active Active
- 2013-07-12 EP EP25178813.9A patent/EP4616915A3/en active Pending
- 2013-07-12 WO PCT/US2013/050337 patent/WO2014012034A1/en not_active Ceased
- 2013-07-12 PT PT138159884T patent/PT2872145T/pt unknown
- 2013-07-12 ES ES13815988T patent/ES2914043T3/es active Active
- 2013-07-12 HR HRP20220701TT patent/HRP20220701T1/hr unknown
2014
- 2014-12-23 IL IL236403A patent/IL236403A0/en unknown
2021
- 2021-05-21 US US17/327,465 patent/US20210275540A1/en not_active Abandoned
- 2021-07-05 IL IL284615A patent/IL284615A/en unknown
2022
- 2022-05-31 CY CY20221100373T patent/CY1125221T1/el unknown

Also Published As

Publication number	Publication date
RS63266B1 (sr)	2022-06-30
IL236403A0 (en)	2015-02-26
SMT202200234T1 (it)	2022-07-21
LT3919060T (lt)	2025-10-10
EP2872145B1 (en)	2022-03-09
US20210275540A1 (en)	2021-09-09
CA2879020C (en)	2021-02-09
KR20150029713A (ko)	2015-03-18
EP2872145A1 (en)	2015-05-20
ES2914043T3 (es)	2022-06-07
PL3919060T3 (pl)	2025-10-20
HUE058696T2 (hu)	2022-09-28
RS67203B1 (sr)	2025-10-31
WO2014012034A1 (en)	2014-01-16
EP2872145A4 (en)	2015-12-02
SI2872145T1 (sl)	2022-07-29
AU2013289922A1 (en)	2015-01-29
AU2013289922B2 (en)	2016-12-15
LT2872145T (lt)	2022-06-27
PT3919060T (pt)	2025-09-25
DK3919060T3 (da)	2025-09-15
EP4616915A3 (en)	2025-12-17
EP3919060B1 (en)	2025-06-18
US11298361B2 (en)	2022-04-12
EP2872145B8 (en)	2022-04-13
PL2872145T3 (pl)	2022-06-20
HK1209336A1 (zh)	2016-04-01
CY1125221T1 (el)	2025-03-28
DK2872145T3 (da)	2022-06-13
JP2015522082A (ja)	2015-08-03
JP6181754B2 (ja)	2017-08-16
IL292725A (en)	2022-07-01
EP3919060A1 (en)	2021-12-08
CA2879020A1 (en)	2014-01-16
SMT202500353T1 (it)	2025-11-10
FI3919060T3 (fi)	2025-09-15
IL300144A (en)	2023-03-01
ES3041320T3 (en)	2025-11-11
HUE072922T2 (hu)	2025-12-28
SI3919060T1 (sl)	2025-11-28
CN104540510A (zh)	2015-04-22
EP4616915A2 (en)	2025-09-17
IL284615A (en)	2021-08-31
HRP20251123T1 (hr)	2025-11-21
HRP20220701T1 (hr)	2022-07-08
US20150164911A1 (en)	2015-06-18

Publication	Publication Date	Title
ITTO20130587A1 (it)	2014-01-14	Nerofumi altamente strutturati
EP2920428A4 (en)	2016-01-06	CARRIER LOCK
CO7010838A2 (es)	2014-07-31	Compuestos de imidazopirrolidinona
CO7061071A2 (es)	2014-09-19	Procesos para la preparación de (s)-1-(3-etoxi-4-metoxifenil)-2-metansulfoniletilamina
EP2854718A4 (en)	2016-02-24	ÖSOPHAGEAL STENT
EP3954300C0 (en)	2025-10-01	ENDOBRONCHIAL CATHETER
DK2818482T3 (da)	2019-07-15	Farmaceutisk sammensætning til behandling af cancer
DK2824114T3 (da)	2019-07-29	Farmaceutisk sammensætning til behandling af cancer
DK2897620T3 (da)	2020-08-17	Fremgangsmåde til behandling af cancer
PT2852391T (pt)	2022-02-18	Sistemas para tratamento de infeções pulmonares
EP2921192A4 (en)	2016-07-27	CATHETER
EP2823767A4 (en)	2015-10-28	CATHETER
EP2832453A4 (en)	2015-11-25	ATOMIZERS
HUE068959T2 (hu)	2025-02-28	Dekódolási eljárás
PT3068786T (pt)	2018-07-26	Compostos de pirazolopirimidina
PL2825212T3 (pl)	2018-06-29	Ulepszony sposób sterylizacji
EP2880228A4 (en)	2015-11-25	FORMWORK SUPPORT ELEMENT
EP2926857A4 (en)	2016-11-02	Catheter
BR112015014842A2 (pt)	2017-07-11	agente de indução de apoptose
PT2750709T (pt)	2018-11-22	Tratamento da caquexia
BR112014022506A2 (pt)	2018-11-06	variantes de cbh1a
IL284615A (en)	2021-08-31	Benzazepines are combined for the treatment of Tourette syndrome
LT2812013T (lt)	2019-07-10	Kompozicija, skirta džs gydymui
HRP20181275T1 (hr)	2018-11-16	Postupak proizvodnje poda vozila za vozilo zaštićeno od mina
EP2883547A4 (en)	2016-02-10	MEDICINE